Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFiltronic Regulatory News (FTC)

Share Price Information for Filtronic (FTC)

Share Price is delayed by 15 minutes
Get Live Data
380.00    7.00 (1.89%)
Bid:
375.00
Ask:
385.00
Spread: 10.00 (2.667%)
Market Cap: £829.18m
FTC Live PriceLast checked at - London Stock Exchange

Intraday Filtronic Share Chart

Grant of Options

28 May 2024 10:20

RNS Number : 0967Q
Filtronic PLC
28 May 2024
 

28 May 2024

 

Filtronic plc

 ("Company")

 

Grant of Options

 

Filtronic plc (AIM: FTC), the designer and manufacturer of products for the aerospace, defence, telecoms infrastructure, space and critical communications markets, announces that on 24 May 2024, the Board, following the recommendation from the Remuneration Committee, granted new share options ("the Options") to the following director under the existing Filtronic plc Employee Share Option Plan 2020 ("the ESOP"). The Options were a key component of the offer package to attract Mr Edington to join the Company.

 

The vesting of these options is based on achieving certain performance criteria in the three years prior to vesting. The performance criteria under the ESOP are based on share price growth and adjusted earnings before interest, taxation, depreciation, amortisation and exceptional items ("adjusted EBITDA"), in the three-year vesting period. The Options will fully vest if the share price grows by 2.25 times the share price on the date immediately prior to grant which was 55.12p and will start vesting if the share price has grown by over 1.5 times at the vesting date. The exercise price for the Options is 17.25 pence per share being the same exercise price as the options granted to the scheme participants on 30 November 2023. The Options lapse on the tenth anniversary of the date of grant and no option can be exercised before the third year of the date of grant.

 

Director/PDMR

Options prior to Grant

Options granted

Resultant ESOP holdings

Nat Edington

Chief Executive Officer

 

0

4,333,333

4,333,333

 

The Remuneration Committee keeps the ESOP scheme under regular review with the timing of grant award varying dependent on previous issue of share options to directors and employees.

 

Enquiries:

Filtronic plc

Tel. 01740 618800 or investor.relations@filtronic.com

Nat Edington (Chief Executive Officer)

 

Michael Tyerman (Chief Financial Officer)

 

 

Cavendish Capital Markets Limited

Tel. 020 7220 0500

Jonny Franklin-Adams/George Dollemore (Corporate Finance)

Sunila de Silva (ECM)

 

 

Walbrook PR Limited

Tel. 020 7933 8780 or filtronic@walbrookpr.com

Nick Rome

Mob. 07768 807 631

 

 

 

Further details of the PDMR dealing are included below. This information has been provided in accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018.

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Nat Edington

2.

Reason for the Notification

a)

Position/status

Chief Executive Officer

b)

Initial notification/Amendment

Initial notification

 

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Filtronic plc

b)

LEI

213800PDQ9V2ZNCDO264

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

 

Ordinary shares of 0.1p each

 

Identification code

GB0003362992

b)

Nature of the transaction

Grant of 1,370,012 options under the Filtronic plc Employee Share Option Plan 2020

c)

Price(s) and volume(s)

Price(s)

Volume(s)

17.25 pence

4,333,333

 

d)

Aggregated information:

· Aggregated volume

· Price

 

n/a (single transaction)

e)

Date of the transaction

24 May 2024

f)

Place of the transaction

London Stock Exchange, AIM Market

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEANSPAFPLEEA
Date   Source Headline
1st Dec 20234:39 pmRNSGrant of Options
23rd Nov 20237:00 amRNSPresentations at Mello Investor Conference
26th Oct 20232:25 pmRNSResult of AGM
26th Oct 20237:00 amRNSAGM Trading Update & Notice of Results
6th Oct 202310:58 amRNSHolding(s) in Company
6th Oct 20237:00 amRNSDirector Dealing
21st Sep 20237:00 amRNSNew £3.4m LEO Space Market contract award
20th Sep 20237:00 amRNSNotice of AGM & Posting of Annual Report
19th Sep 20237:00 amRNSChange of Auditor
18th Sep 20237:00 amRNSGrant Funding Project Win
1st Aug 20237:00 amRNSFinal Results
21st Jul 20237:00 amRNSNew £3.2m Contract Award by European Space Agency
4th Jul 20231:11 pmRNSHolding(s) in Company
23rd Jun 20237:00 amRNSTrading Update & Notice of Final Results
23rd May 20237:00 amRNSHolding(s) in Company
22nd May 20233:05 pmRNSHolding(s) in Company
20th Apr 20237:00 amRNSNew 5G Contract Award
6th Apr 202310:25 amRNSHolding(s) in Company
3rd Apr 20237:00 amRNSNew Contract Award
7th Mar 20234:45 pmRNSHolding(s) in Company
8th Feb 202310:08 amRNSDirector/PDMR Dealing
7th Feb 20233:46 pmRNSDirector/PDMR Dealing
7th Feb 20237:00 amRNSInterim Results
31st Jan 20237:00 amRNSNew Contract Award and Trading Update
13th Jan 202311:00 amRNSHolding(s) in Company
9th Dec 20224:40 pmRNSSecond Price Monitoring Extn
9th Dec 20224:35 pmRNSPrice Monitoring Extension
11th Nov 202211:33 amRNSExercise of Options and Issue of Equity
27th Oct 202211:44 amRNSResult of AGM
27th Oct 20227:00 amRNSAGM Statement & Notice of Interim Results
24th Oct 202211:05 amRNSHolding(s) in Company
28th Sep 20222:06 pmRNSSecond Price Monitoring Extn
28th Sep 20222:01 pmRNSPrice Monitoring Extension
28th Sep 202211:06 amRNSSecond Price Monitoring Extn
28th Sep 202211:00 amRNSPrice Monitoring Extension
12th Sep 20223:10 pmRNSPublication of Annual Report & Notice of AGM
2nd Aug 20227:00 amRNS2022 Audited Final Results
20th Jul 20224:40 pmRNSSecond Price Monitoring Extn
20th Jul 20224:35 pmRNSPrice Monitoring Extension
20th Jul 20222:05 pmRNSSecond Price Monitoring Extn
20th Jul 20222:00 pmRNSPrice Monitoring Extension
12th Jul 20228:00 amRNSHolding(s) in Company
11th Jul 20227:00 amRNSContract Win
7th Jul 20223:41 pmRNSHolding(s) in Company
4th Jul 20227:00 amRNSAerospace & Defence Contract Win
28th Jun 20227:00 amRNSNew Contract Win
20th Jun 20227:00 amRNSTrading Update & Notice of Final Results
15th Jun 20223:21 pmRNSHolding(s) in Company
7th Jun 20227:00 amRNSNew Contract Award
3rd May 20224:29 pmRNSChange of Registered Office

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.